Dr Mahendra provides professional advisory services to HCA The Harborne Hospital to develop the haemato-oncology and cellular therapy services and chair the haematology MDT.
Dr Mahendra owns 3.2% shares in LOC@THH (Leaders in Oncology @ The Harborne Hospital)